Published in Hematology Week, October 2nd, 2006
Researchers working in England report, "We investigated whether (endogenous) hydrogen sulfide (H2 S) protects the heart against myocardial ischemia and reperfusion injury. Furthermore, we investigated whether endogenous H2 S is involved in the protection afforded by
(1) ischemic preconditioning and
(2) the second window of protection caused by endotoxin."
"The involvement of one of the potential...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.